Detalhe da pesquisa
1.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587254
2.
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.
Circulation
; 149(6): 450-462, 2024 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952217
3.
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation
; 2024 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583093
4.
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
N Engl J Med
; 386(2): 128-137, 2022 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735046
5.
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
Circulation
; 148(12): 950-958, 2023 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602376
6.
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis.
Kidney Int
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38537676
7.
Milvexian for the Prevention of Venous Thromboembolism.
N Engl J Med
; 385(23): 2161-2172, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780683
8.
Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events.
J Card Fail
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614444
9.
Real-world walking behaviors are associated with early-stage heart failure: a Project Baseline Health Study.
J Card Fail
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38582256
10.
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials.
J Am Soc Nephrol
; 34(12): 1965-1975, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37876229
11.
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER.
Circulation
; 145(8): 575-585, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903039
12.
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials.
Circulation
; 145(19): 1460-1470, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394821
13.
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
Circulation
; 146(23): 1735-1745, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335914
14.
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Circulation
; 145(4): 242-255, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985309
15.
Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group.
Kidney Int
; 103(6): 1028-1037, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023851
16.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Am J Kidney Dis
; 82(1): 84-96.e1, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889425
17.
Clinical and Echocardiographic Diversity Associated With Physical Fitness in the Project Baseline Health Study: Implications for Heart Failure Staging.
J Card Fail
; 29(11): 1477-1489, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116641
18.
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE.
Cardiovasc Diabetol
; 22(1): 100, 2023 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120538
19.
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
Nephrol Dial Transplant
; 38(9): 2041-2051, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651820
20.
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials.
Diabetes Obes Metab
; 25(8): 2151-2162, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37161691